Health
1.9
Gilead oral IBS drug eliminates symptoms in mid-stage trial
Published 2 d ago1 sourceEvidence: Reported
STAT NewsLow-rated source
HealthReportedMedium
5.0
Roivant's immune drug succeeds in non-infectious uveitis trial, eyes new market
Roivant reported positive trial results for its immune drug in non-infectious uveitis, a new indication. The drug, already approved for other conditions, could expand its market. Regulatory approval and commercial impact remain uncertain.
Score Breakdown
Mosaic Score5.0
Model confidence0.7
Significance0.5
Source credibility0.1
Intelligence Tags
Entities
United Statescountry
Related signals
8 foundHealth
5.6
US-backed hepatitis B vaccine trial in Guinea-Bissau halted after backlash
Published 9 h ago2 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storyGuardian WorldLow-rated sourceUS · GW · GN
Politics
5.5
Belgium healthcare budget deal collapses as employers reject savings plan
Published 2 d ago2 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storyLe SoirLow-rated sourceBE
Health
5.3
Guinea-Bissau seizes vaccines from WHO-deemed unethical infant trial
Published 7 h ago2 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storyEl UniversoLow-rated sourceGW · GN
Politics
5.3
Belgian Union Setca Slams State Aid to GSK Amid Layoffs, Cites Lack of Job Guarantees
Published 2 d ago3 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storyLe SoirLow-rated sourceBE
Health
5.1
GSK wins FDA approval for hepatitis B drug, expands functional cure rates
Published 11 h ago1 sourceEvidence: Reported
SeverityModerateSTAT NewsLow-rated sourceUS
Health
5.0
Libya's $2.4B drug spend fails patients; expired meds, procurement flaws exposed
Published 15 h ago1 sourceEvidence: Reported
SeverityModerateAl Jazeera ARLY
Justice
4.9
Argentine prosecutors allege pharmacy cartel overpricing scheme in Andis drug scandal
Published 9 h ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storyLa Nación (Argentina)Low-rated sourceAR